Results 171 to 180 of about 25,426 (206)

PARP1 deficiency mitigates amyloid pathology, neurodegeneration, and cognitive decline in a familial Alzheimer's disease model. [PDF]

Proc Natl Acad Sci U S A
Jhaldiyal A, Kumari M, Guttman LC, Tripathi T, Khan MR, Wang J, Biswas D, Pasupuleti A, Aggarwal A, Pandya S, Chou SC, Panicker N, Monghekar A, Albert M, Bekris LM, Leverenz JB, Kam TI, Dawson TM, Dawson VL.   +18 more
europepmc   +1 more source

Comprehensive metabolomic profiling of Egyptian Salvia species reveals promising leads for chemopreventive and anti-inflammatory drug development: In vitro and In silico study. [PDF]

Sci Rep
Hamed AR, Ali SK, Abdel-Halim SA, Bata SM, Hegazi NM, Mohamed TA, Hegazy MF.   +6 more
europepmc   +1 more source

SARM1 executes neuronal parthanatos and promotes excitotoxic cell death. [PDF]

Neuron
Wu T, Yuan L, Sasaki Y, Chen SJ, Buchser W, Bloom AJ, DiAntonio A, Milbrandt J.   +7 more
europepmc   +1 more source

CHD1L maintains genome integrity by facilitating okazaki fragment maturation. [PDF]

Nucleic Acids Res
Nie L, Fu J, Huang M, Zhang H, Ma T, Yang C, Li S, Wang C, Chen J.   +8 more
europepmc   +1 more source

Disrupting USP14-mediated PARP1 dynamics reinstates MIC-A/B-driven antigen-independent CD8⁺ T cell killing in glioma. [PDF]

Sci Adv
Wang M, Yu S, Zhang C, Cheng Q, Gong Z, Li X, Huang T, Wang X, Jiang X, Li J.   +9 more
europepmc   +1 more source

PARylation-centric crosstalk: orchestrating immune evasion and multidrug resistance in ovarian cancer. [PDF]

Front Immunol
Hou L, Zhang M, Tong W, Zhang S.
europepmc   +1 more source

Nicotinamide Ameliorates Deoxynivalenol-Induced Injury in Renal Cells via Inhibiting PARP1 Hyperactivation and Restoring NAD⁺ Homeostasis. [PDF]

Toxins (Basel)
Chen C, Qin Y, Luo Z, Mu P, Wen J, Deng Y.   +5 more
europepmc   +1 more source

Identifying potential binding sites for complex formation between Tyrosyl-DNA phosphodiesterase 1 and poly [ADP-ribose] polymerase 1.

Phys Chem Chem Phys
Wang S, Üren A, Tiwari PB.
europepmc   +1 more source

PARP inhibitors and breast cancer: from therapeutic breakthrough to resistance challenge. [PDF]

Exp Mol Med
Wang W, Cai C, Qin S, He L, Liang Q, Tang S, Xie J, Long T, Hou J, Kim W, Zhao F.   +10 more
europepmc   +1 more source

NAD⁺ metabolism at the host-virus interface. [PDF]

J Gen Virol
Jhandai P, Vaddadi K, Liu L.
europepmc   +1 more source